Who owns Cue Biopharma Inc?
- Ticker: CUE
- CUSIP Number: 22978p106
Tip: Access positions for across all investors
Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Cue Biopharma stock
Who bought or sold Cue Biopharma Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Bleichroeder | 5.0M | $5.4M | 0% | Dec 2024 |
|
Vanguard Group | 2.1M | $2.2M | 1% | Dec 2024 |
|
BlackRock | 639k | $697k | 12% | Dec 2024 |
|
Geode Capital Management | 631k | $688k | 24% | Dec 2024 |
|
Robertson Stephens Wealth Management | 479k | $522k | 0% | Dec 2024 |
|
Sigma Planning | 447k | $487k | 11% | Dec 2024 |
|
Good Life Advisors | 400k | $436k | 0% | Dec 2024 |
|
Bank of America Corporation | 324k | $354k | 36% | Dec 2024 |
|
Advisory Research | 257k | $280k | 0% | Dec 2024 |
|
Stifel Financial | 211k | $230k | 9% | Dec 2024 |
|
Northern Trust | 208k | $208k | 51% | Dec 2024 |
|
State Street Corporation | 190k | $207k | 7% | Dec 2024 |
|
GSA Capital Partners | 150k | $163k | -49% | Dec 2024 |
|
HighTower Advisors | 128k | $140k | 54% | Dec 2024 |
|
Millennium Management | 69k | $76k | -81% | Dec 2024 |
|
Jane Street | 64k | $70k | 146% | Dec 2024 |
|
UBS Group | 58k | $64k | -21% | Dec 2024 |
|
Hrt Financial | 49k | $53k | 100% | Dec 2024 |
|
XTX Topco | 47k | $51k | 70% | Dec 2024 |
|
LPL Financial | 43k | $47k | 139% | Dec 2024 |
|
Goldman Sachs Group | 35k | $38k | 86% | Dec 2024 |
|
Texas Capital Bank Wealth Management Services | 33k | $36k | 100% | Dec 2024 |
|
Morgan Stanley | 29k | $31k | -15% | Dec 2024 |
|
Point72 Asia | 28k | $30k | 15% | Dec 2024 |
|
Navalign | 25k | $27k | 100% | Dec 2024 |
|
Susquehanna International | 25k | $27k | 100% | Dec 2024 |
|
Wells Fargo & Company | 20k | $22k | 0% | Dec 2024 |
|
Cambridge Investment Research Advisors | 20k | $22k | 0% | Dec 2024 |
|
Squarepoint Ops | 20k | $22k | 100% | Dec 2024 |
|
Virtu Financial | 17k | $18k | 100% | Dec 2024 |
|
SeaCrest Wealth Management | 13k | $14k | 0% | Dec 2024 |
|
Citadel Advisors | 12k | $13k | -29% | Dec 2024 |
|
Tower Research Capital | 11k | $12k | 46% | Dec 2024 |
|
Beacon Pointe Advisors | 10k | $11k | 0% | Dec 2024 |
|
Simplex Trading | 6.9k | $7.0k | 70% | Dec 2024 |
|
Barclays | 6.0k | $7.0k | 0% | Dec 2024 |
|
Gleason Group | 6.0k | $6.5k | 0% | Dec 2024 |
|
Cubist Systematic Strategies | 3.7k | $4.0k | 100% | Dec 2024 |
|
Newbridge Financial Services Group | 3.0k | $3.3k | 0% | Dec 2024 |
|
Goss Wealth Management | 2.6k | $2.8k | 0% | Dec 2024 |
|
Northwestern Mutual Wealth Management Company | 2.5k | $2.7k | 0% | Dec 2024 |
|
Golden State Wealth Management | 2.0k | $2.2k | 100% | Dec 2024 |
|
Larson Financial Group | 1.4k | $1.5k | 0% | Dec 2024 |
|
Jpmorgan Chase & Co | 1.1k | $1.2k | 17% | Dec 2024 |
|
UMA Financial Services | 1.0k | $1.1k | 100% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 854.00 | $931.030800 | 7% | Dec 2024 |
|
MAI Wealth Advisors | 350.00 | $381.990000 | 100% | Dec 2024 |
|
Sunbelt Securities | 237.00 | $242.000700 | 0% | Dec 2024 |
|
Armstrong Advisory Group | 120.00 | $131.004000 | 0% | Dec 2024 |
|
IFP Advisors | 100.00 | $109.000000 | 0% | Dec 2024 |
|
FMR | 96.00 | $105.004800 | -66% | Dec 2024 |
|
Point72 | 66.00 | $71.999400 | 14% | Dec 2024 |
|
Stonebridge Financial Group | 62.00 | $68.001600 | 100% | Dec 2024 |
|
Citigroup | 43.00 | $46.999000 | 0% | Dec 2024 |
|
SBI Securities | 1.00 | $1.000000 | 100% | Dec 2024 |
|
Who sold out of Cue Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Slate Path Capital | Sep 2024 | 2.4M | $1.8M |
Qube Research & Technologies | Sep 2024 | 25k | $19k |
Mirae Asset Global Etfs Holdings | Jun 2024 | 18k | $22k |
Dimensional Fund Advisors | Sep 2024 | 15k | $11k |
Legacy Capital Group California | Sep 2024 | 10k | $7.6k |
Catalyst Funds Management Pty | Jun 2024 | 9.0k | $11k |
Harbour Investments | Sep 2024 | 439.00 | $332.015700 |
Advisor Group Holdings | Sep 2024 | 380.00 | $288.002000 |
SRS Capital Advisors | Sep 2024 | 215.00 | $162.991500 |